Beyond its well-characterized functions in antibody diversification, the cytidine deaminase AID can catalyze off-target DNA damage and has been hypothesized to edit RNA and mediate DNA demethylation. To comprehensively examine the effects of AID on the transcriptome and the pattern of DNA methylation ('methylome'), we analyzed AID-deficient (Aicda −/− ), wildtype and AID-overexpressing activated B cells by high-throughput RNA sequencing (RNA-Seq) and reduced-representation bisulfite sequencing (RRBS). These analyses confirmed the known role of AID in immunoglobulin isotype switching and also demonstrated few other effects of AID on gene expression. Additionally, we detected no evidence of AID-dependent editing of mRNA or microRNA. Finally, the RRBS data did not support the proposed role for AID in regulating DNA methylation. Thus, despite evidence of its additional activities in other systems, antibody diversification seems to be the sole physiological function of AID in activated B cells.
Germinal center B cells undergo two processes of immunoglobulin diversification: somatic hypermutation (SHM), in which mutations are introduced into immunoglobulin genes, and class-switch recombination (CSR), in which genomic sequences encoding constant regions are recombined to encode antibodies of different isotypes. Both of those processes require the cytidine deaminase AID 1, 2 , which generates cytidine-to-uridine lesions at immunoglobulin loci that are resolved to generate point mutations or double-stranded DNA breaks in SHM or CSR, respectively 3 .
Despite over a decade of intense study, many outstanding questions about AID remain. The first is about its range of substrates. Because of its homology to the well-characterized RNA-editing enzyme APOBEC1, AID was initially thought to deaminate an RNA substrate 1 . Since then, roles of AID in CSR and SHM have been convincingly shown to proceed by a DNA-editing mechanism 4 , and no AID activity has been detected on RNA substrates in vitro [5] [6] [7] . However, AID has been shown to bind mRNA 7, 8 , to modulate translation 9 and to edit the genome of hepatitis B virus 10 , which has led to the hypothesis that it could edit RNA in vivo in conjunction with an unknown sequence motif or cofactor.
Additionally, AID has been shown to act on non-immunoglobulin loci in B cells 11, 12 . Such off-target events can result in the mutation of oncogenes and genes encoding tumor suppressors 13, 14 and have been linked to oncogenic chromosomal translocations in B cell lymphomas [15] [16] [17] [18] [19] . AID expression has also been reported in many different types of non-B cell tumors, in which it has been hypothesized to contribute to malignant progression 20 . In support of such off-target activities, chromatin-immunoprecipitation experiments have indicated AID occupancy at a large number of promoters beyond the immunoglobulin loci 21 . However, the transcriptional consequences of such off-target activities for the typical B cell have not been determined.
Furthermore, many experiments in a variety of systems have suggested that AID might also have a role in active DNA demethylation and corresponding gene regulation [22] [23] [24] [25] [26] [27] [28] . Because AID is active on 5-methylcytosine in DNA 22 , it has been hypothesized that active demethylation could occur by AID-catalyzed deamination of 5-methylcytosine, followed by error-free repair of the resulting thymidine-guanosine mismatch 29 . That model has been supported by reports linking AID to DNA demethylation in a variety of systems [23] [24] [25] [26] 30 . However, those findings are puzzling given the low abundance of AID in many of those systems and the greater catalytic activity of AID on cytidine than on 5-methylcytosine 31, 32 . Additionally, it is clear that AID is not absolutely required for active demethylation during development, as indicated by the viability and fertility of AID-deficient mice 1 .
To answer the outstanding questions about AID activity on RNA and its ability to mediate DNA demethylation, we sought to systematically characterize the transcriptome and the pattern of DNA methylation ('methylome') of AID-deficient (Aicda −/− ), wild-type and AID-overexpressing activated mouse B cells. These studies demonstrated AID-dependent effects at immunoglobulin loci but A r t i c l e s did not show additional AID-dependent transcriptional differences. Furthermore, we were unable to detect AID-dependent RNA-editing activity, which suggested that despite the initial models, AID does not act as an RNA editor in B cells. Finally, our analysis of the methylome of activated B cells showed no DNA-methylation differences attributable to AID, even when AID was overexpressed. Overall, our data suggested that, at least in B cells, AID acted nearly exclusively in its well-described role in immunoglobulin diversification.
RESULTS

Little effect of AID on gene expression
To determine the effects of AID on the B cell transcriptome, we used 100-nucleotide, single-end high-throughput RNA sequencing (RNA-Seq) to analyze polyadenylated RNA from naive splenic B cells from mice of the following three genotypes: Aicda −/− , wild-type and AID-miR-155T (a fusion of AID and green fluorescent protein (GFP) that lacks the miR-155 target sequence in its 3′ untranslated region, which results in AID overexpression) 33 . We stimulated isolated B cells for 72 h ex vivo with lipopolysaccharide, interleukin 4 and antibody to CD40. These conditions induced substantial expression of AID and an appreciable frequency of CSR to immunoglobulin G1 (IgG1; 14% for wild-type and 31% for AID-miR-155T; Supplementary Fig. 1 ). We prepared RNA-Seq libraries by a standard protocol with the addition of two sets of 'spike-in' control transcripts: a panel of RNA from the External RNA Controls Consortium (ERCC) 34 (to ascertain the lower limit of detection for gene expression), and five 'pre-edited' RNAs derived from Trypanosoma brucei genes encoding variant surface glycoprotein (VSG) with a single cytidine-to-thymidine change introduced at a frequency of 50% (to serve as a positive control for the detection of RNA editing).
To determine the lower bound of accurate transcript measurement, we calculated the abundance of ERCC spikes. Estimates of abundance were extremely well correlated for each pair of samples for transcripts with more than five fragments per kilobase of transcript per million mapped 'reads' (FPKM), a relative measure of transcript abundance ( Supplementary Fig. 2 ). This analysis demonstrated that even poorly expressed transcripts were well covered in these RNA-Seq data sets.
Overall, the gene-expression profiles were extremely similar for the three samples, with a Pearson correlation coefficient of >0.995 for each pairwise comparison ( Fig. 1a and Supplementary Fig. 3a,b ). In these expression profiles, AID itself had the expected expression in each data set. However, other than AID, the short list of genes with greater-than-twofold difference in expression between conditions (Supplementary Table 1 ) was composed of elements annotated mainly as pseudogenes in other references or elements with RNA-Seq coverage characteristic of mismapped 'reads' derived from paralogous transcripts. In addition, few transcripts with a difference in expression of over twofold had such a difference in more than one of the binary comparisons, which suggested that these apparent differences were the result of 'noise' rather than being authentic AID-dependent effects. These findings were concordant with those from an RNA-Seq comparison of Aicda −/− and wild-type samples of lower depth under slightly different conditions (36-nucleotide paired-end sequencing, and stimulation with interleukin 4 plus antibody to CD40; Supplementary Fig. 3c ).
We also used the RNA-Seq data to estimate the abundance of transcript isoforms. Expression analysis at the isoform level showed a high degree of similarity among Aicda −/− , wild-type and AID-miR-155T samples, except for immunoglobulin transcripts ( Fig. 1b and Supplementary  Fig. 3d,e ). Again, we also found a high degree of similarity in the RNA-Seq runs of lower depth (Supplementary Fig. 3f ). Although these results did not exclude the possibility of AID-dependent changes in gene expression in B cells, they demonstrated that if such changes existed outside the immunoglobulin heavy-chain (Igh) locus, they were probably too small to be physiologically relevant.
The notable exception to that trend was transcripts derived from the Igh locus. By including a manually curated annotation for the Igh locus (Supplementary Table 2 ), we were able to estimate relative frequency of CSR by comparing the abundance of transcripts spliced from the joining regions of Igh to the constant region for each immunogluin isotype (J H -C). As expected, nearly all J H -C-spliced transcripts for the Aicda −/− sample were from loci encoding IgM or IgD, whereas the wild-type and AID-miR-155T samples both had appreciable amounts of transcripts encoding IgE, IgG1, IgG2a and IgG3 (Fig. 1c) . Furthermore, the apparent CSR frequency was higher for the AID-miR-155T sample than for the wild-type sample for each secondary isotype, consistent with published reports 33 .
To determine how CSR frequency quantified by RNA-Seq analysis compared with standard measurements, we compared the fraction of IgG1 + cells as determined by flow cytometry and the abundance of Fig. 3g ). We observed a distinct linear relationship, albeit with slope not equal to 1, which probably represented different per-cell amounts and/or sequencing efficiencies of different isotype transcripts. Determining these correction factors for each isotype should allow the use of RNA-Seq as a quantitative tool for assaying the absolute frequency of CSR.
No effect of AID on V H segment use AID deficiency has been associated with autoimmune disease and a skewed pattern of the use of heavy-chain variable (V H ) segments in both humans 35 and mice 36 . We sought to determine whether the influence of AID on V H use was apparent in our RNA-Seq data sets. Because our data were derived from naive B cells nonspecifically stimulated to undergo CSR ex vivo, any differences between samples in their V H use should mirror the in vivo repertoire before affinity maturation.
We used our RNA-Seq data to derive FPKM values for the entire set of V H segments; this provided a measure of the relative segment use by samples. This transcript-abundance analysis showed only minor differences among Aicda −/− , wild-type and AID-miR-155T samples in the abundance of transcripts encoding V H segments. Notably, none of these showed a distinct relationship to AID expression ( Supplementary Table 3 ), which suggested that the pattern of V H use was unaffected by AID. This result was in contrast to the pattern of V H use in newly emigrant B cells in AID-deficient humans 21, 35 , which suggests that the influence of AID on V H use occurs after establishment of the primary repertoire and probably reflects the dynamics between AID-mediated affinity maturation and B cell survival, rather than a role in early B cell development.
No detectable AID-dependent RNA editing
The utility of comparative RNA-Seq of paired samples with and without a specific deaminase for identifying RNA-editing events has been demonstrated 37 . Because AID has long been hypothesized to act on RNA 1,8 , we applied a similar analysis workflow to our B cell RNA-Seq data. We considered single-nucleotide variants (SNVs) to be candidate editing sites if they had coverage of more than 30 'reads' with at least 20% apparent cytidine-to-thymidine editing, were a minimum distance from an SNV that was not a cytidine-to-thymidine substitution (1 kilobase when the reference from the Ensembl project genome database was used; 10 kilobase otherwise), were not significantly strand biased, were not located in regions that were not isogenic in the mice used and did not occur in the Aicda −/− sample. We did parallel analyses for positions in Ensembl reference exons (to achieve the lowest possible background) and for all positions (to include positions in transcripts not found in the reference annotation).
To estimate the fraction of the transcriptome covered by this technique, we computed the amount of coverage by base for ERCC spikes with various FPKM values ( Fig. 2a) . Over 90% of bases of the transcripts with an FPKM value of ≥10 were covered by at least 30 'reads' , whereas those with an FPKM value of 8 had sufficient depth for about 60% of bases to be investigated for editing by our strategy. For the B cell RNA-Seq data sets, the ~6,600 transcripts with the highest expression had an FPKM value of ≥ 10 and were thus well covered by the RNA-editing analysis. Additionally, the editing event in the exogenous 'pre-edited' VSG RNA with an FPKM value of 23 was detected, but that with an FPKM value of 7 was not. Thus, this analysis strategy was appropriate for identifying editing events for transcripts with moderate to high expression.
To verify that our strategy was able to effectively identify RNA editing events, we applied the pipeline to sets of RNA-Seq data from macrophages lacking the true RNA editor APOBEC1 and a paired wild-type control (C. Hamilton et al., personal communication). Many unique cytidine-to-thymidine events present in the wild-type sample were absent from the Apobec1 −/− sample (Fig. 2b) . When we made the reciprocal comparison, we found very few appropriate SNVs in the Apobec1 −/− sample that were absent from the wild-type sample. The small number of such events, which were probably due to mismapping or genomic differences between the mice from which the cells were derived, demonstrated the low background of the technique. The ratio of unique editing events in the deaminase-negative sample to those in the deaminase-positive sample yielded an implied false-positive rate for identification of the candidate editing events.
Application of the editing-site-identification pipeline to the B cell RNA-Seq data identified very few candidate editing sites in the AID-miR-155T and wild-type samples that were absent from the Aicda −/− sample (Fig. 2c) . We found an approximately equal number npg A r t i c l e s of candidate sites by the reciprocal comparison, which resulted in implied false-positive rates of >75% for each condition. In contrast, the implied false-positive rate for APOBEC1-dependent editing in macrophages was 7-8%. We visually inspected RNA-Seq mapping data for the few candidate AID-dependent editing events and in each case judged these events to be false-positive results because they met one of the following criteria: near-threshold distance from SNVs that were not cytidine-to-thymidine substitutions, cytidine-to-thymidine mismatches also occurred in the Aicda −/− sample or a complete absence of apparent editing in the AID-miR-155T sample. Thus, although we detected APOBEC1-catalyzed editing of mRNA by this method, we did not detect AID-dependent editing of polyadenylated RNA with moderate or high expression. AID has also been linked the mutation of genes encoding micro-RNAs (miRNAs) 17 as well as the editing of miRNAs themselves 9, 38 . We therefore sought to characterize the effects of AID deficiency on the full set of miRNAs. We retrovirally transduced Aicda −/− naive B cells in culture to overexpress GFP alone or AID and GFP, stimulated them for 24 or 48 h and analyzed them by high-throughput sequencing of miRNA (miRNA-Seq). For both time points, miRNA abundance was well correlated for the samples (Pearson correlation coefficient, >0.95; Fig. 3a) . Thus, AID seemed to have no effect on the abundance of mature miRNA.
To determine whether AID acted as an editor of miRNA, we used a strategy to detect RNA editing similar to that used for mRNA. In this strategy, positions with at least 10% mismatches and with coverage by at least ten 'reads' are identified and classified by type of base change. Cytidine-to-thymidine changes were among the least common base alterations observed (Fig. 3b) . For each base-change type, including cytidine to thymidine, the frequency observed was approximately the same for each sample. These probably represented sequencing error, mismapping or other types of RNA editing that do not depend on AID. For example, adenosine-to-guanosine alterations constitute the most common change observed for all samples and are possibly the results of editing catalyzed by the RNA-editing enzyme ADAR [39] [40] [41] [42] .
To look more specifically at potential AID-dependent editing, we analyzed unique mismatched sites, which we defined as events that did not occur in the corresponding sample at the same time point with a threshold of lower depth. Again, cytidine-to-thymidine sites were among the least frequent ( Fig. 3c) . Only one cytidineto-thymidine site for each of the AID-overexpressing samples fulfilled those criteria. Those sites did not seem to be authentic RNA editing, as they had insufficient depth in the GFP-overexpressing AID-deficient sample for comparison and they occurred at a frequency of nearly 100%, which suggested a genomic SNV or mismapping. Thus, if AID-catalyzed editing of miRNA occurred, it did so at a rate well below the background of the sequencing protocol and was therefore unlikely to be physiologically important.
No detectable AID-dependent DNA-methylation changes
Given the many results suggesting a role for AID in DNA demethylation, we sought to identify differences in the methylomes of Aicda −/− , wild-type and AID-miR-155T B cells. To obtain genome-scale methylation data while minimizing the amount of uninformative sequencing, we used reduced-representation bisulfite sequencing (RRBS) 43 . Through digestion with MspI and size selection before library preparation and bisulfite conversion, RRBS allows sequencing coverage to be focused on the CpG-rich, gene-rich portion of the genome. Our coverage data reflected such enrichment (64% of promoters and 85% of CpG islands with ≥100 individual CpG measurements), despite low overall genomic coverage (2% of 1-kilobase windows with ≥100 individual CpG measurements; Supplementary Fig. 4) . Overall, nearly 9.5 × 10 5 CpG sites were covered by at least ten 'reads' in all three samples and were used for further analysis.
To determine whether AID had a gross effect on the methylome of B cells, we compared the distribution of methylation frequency for various genomic features of the three AID genotypes. For each genomic feature type analyzed (1-kilobase windows, individual CpG sites, CpG islands and promoters), there was no apparent difference in DNAmethylation distribution associated with AID expression (Fig. 4) . 
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The mean methylation frequency for each set of features was very similar for all three genotypes. For each feature type, we observed the expected bimodal distribution of methylation, as proportionally more 1-kilobase windows than the other feature types were fully methylated.
To assess more subtle differences in DNA methylation by AID expression, we compared the methylation frequencies of individual features for each pair of samples. For each feature set analyzed, the methylation frequency of the samples showed strong correlation (Fig. 5a,b and Supplementary Fig. 5a-d) . For 1-kilobase windows, we observed r values of 0.997-0.998 for each pair; in comparison, the maximum reported r value for methylation frequencies of 1-kilobase windows for biological replicates of cells of the hematopoietic lineage is 0.997 (ref. 44) .
The high degree of correlation of methylation values did not exclude the possibility that sampling 'noise' could have masked small numbers of true AID-dependent changes in methylation. To determine if this was the case, we sought to independently verify the largest apparent AID-dependent decreases in DNA methylation identified by RRBS. For this we used EpiTYPER technology for the detection and quantitative analysis of DNA methylation to assay regions with >20% more methylation in the Aicda −/− sample than in the wild-type sample, as measured by RRBS, along with randomly selected regions with a difference in methylation of <10% between samples. We obtained highquality data for all three samples for eight apparently AID-dependent hypermethylated CpG sites and eighteen similarly methylated CpG motifs that were also well covered by RRBS.
For the candidate CpG sites with a difference in methylation, the methylation frequencies for the Aicda −/− sample as determined by RRBS were generally much higher than those determined by EpiTYPER (Fig. 5c) . In contrast, these methods provided similar values for the wild-type and AID-miR-155T samples. The findings that we were unable to confirm the apparent examples of AID-dependent hypermethylation and that these CpG sites yielded uniformly lower methylation values when assayed by an independent technique suggested that the RRBS-derived values for these sites represented overestimation of the true population mean methylation frequency, due to 'noise' or an artifact of the method. Additionally, the set of CpG sites with similar methylation values in the samples by RRBS showed excellent agreement in methylation frequencies as determined by the two methods ( Fig. 5d) , which demonstrated that RRBS as done here yielded accurate methylation values for well-covered CpG sites. npg A r t i c l e s Together these results suggested that the most extremely hypermethylated CpG sites in the Aicda −/− sample were not the result of an authentic AID-dependent process.
Finally, in an attempt to locate any subtle but biologically meaningful AID-dependent changes in DNA methylation, we compared changes in gene expression by RNA-Seq with changes in promoter methylation for each pair of samples ( Fig. 5e and Supplementary  Fig. 5e,f) . Each pairwise comparison of genotypes showed that these variables were uncorrelated (|r| < 0.03 for all), which suggested that the observed modest differences in DNA methylation were not associated with changes in gene expression and therefore were unlikely to be physiologically relevant. As a whole, these results demonstrated that we were not able to identify any candidate for consistent AIDdependent loss of methylation in B cells by RRBS.
DISCUSSION
Many studies have proposed roles for AID in RNA editing and DNA demethylation. Here we sought to examine those hypotheses in activated B cells through the use of genome-wide methods to comprehensively characterize the effects of AID on the transcriptome and methylome. Toward that goal, we analyzed material from Aicda −/− , wild-type and AID-overexpressing cells by mRNA sequencing, miRNA sequencing and RRBS. The resulting data allowed RNAexpression analysis at the level of the gene, isoform and miRNA, detection of RNA editing by a validated pipeline and determination of quantitative methylation values for nearly 1 × 10 6 CpG sites.
The ability of AID to edit RNA in vivo has remained an open question for over a decade 1 . The advent of high-throughput RNA sequencing has made possible the comprehensive characterization of enzyme-specific RNA editing 37 , which has finally allowed this issue to be resolved. We used a bioinformatics pipeline that can successfully identify APOBEC1-dependent RNA editing to investigate AID-dependent RNA editing in the transcriptome of B cells. For transcripts with moderate to high expression, and with a lower limit of detection of 20% editing frequency, we were not able to detect AIDdependent editing. With the assumption that low-efficiency editing of transcripts with low expression is probably not a crucial determinant of a mechanism as efficient as CSR or SHM, our data indicate that AID probably does not exert its effects on antibody diversity through RNA editing.
Our comparative RNA-Seq data also allowed analysis of the population-level transcriptional consequences of AID activity. One notable finding was the lack of AID-dependent changes in gene expression, despite the known ability of AID to catalyze hypermutation 12, 21 and translocations 17, 18 at loci throughout the genome in B cells. Although certain varieties of AID-dependent DNA damage have deleterious effects on B cell function 16 , the lack of AID-dependent differences in gene expression or DNA methylation that we observed would suggest that such biologically meaningful off-target AID activity at a given locus is rare in absolute terms. Therefore, whereas AID can act at many places in the genome, at the population level its only observable activities at the transcriptional level are at the immunoglobulin loci. We note that none of the analyses presented here were direct measurements of the frequency of off-target AID activity or AID occupancy in the genome itself; although measurements of SHM and translocation frequency are theoretically possible with data obtained by mRNA sequencing, they are below the limit of detection for the systems and depth of sequencing presented here.
Finally, AID has been proposed to act in DNA demethylation in a variety of systems [23] [24] [25] [26] [27] [28] . Despite published data showing AID occupancy throughout the genome 21 and DNA demethylation concurrent with B cell activation 45 , we observed no AID-dependent demethylation events in activated B cells. There are many possible explanations for this discrepancy. It is possible that AID does not catalyze DNA demethylation at all in B cells because cofactors required for AIDdependent DNA demethylation are not present in B cells, or that B cells have some other factor that prevents deleterious demethylation in the presence of AID. Alternatively, AID-dependent demethylation in B cells could be obscured by rapid remethylation-for example, by the methyltransferase DNMT1. It is also possible that the 'weaker' DNA-methylation phenotype of AID-deficient mammals than that of Danio rerio 24 could be related to differences among these species in the efficiency with which AID deaminates 5-methylcytosine 46 . Regardless of those possibilities, if AID can act as a DNA demethylase, it does so below the limits of detection of our analyses, in an extremely targeted manner at loci not covered by RRBS, or in a cell type-specific manner (and not in mouse B cells stimulated ex vivo). Overall, the lack of AID-dependent differences in all our analyses, except for immunoglobulin isotype use, suggests that the sole function of AID in B cells is its well-characterized role in the initiation of CSR and SHM. In addition to confirming a narrow role for AID action in B cells, our analyses here have also demonstrated the broad applicability of RNA-Seq for the study of B cell biology. In addition to its standard use as a gene-expression assay, its utility in detecting RNA editing, CSR frequency and V H segment use demonstrates its flexibility as a tool for characterizing populations of B cells.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. Sequence Read Archive: raw mRNA sequencing and trimmed miRNA sequencing and RRBS 'reads' , SRP020240.
